CRAIG ADAM R (President and CEO) sold 79.7% of their position (115.58K shares) of CTI BIOPHARMA CORP on the open market
Open‑market sale worth $694.7K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
common stock
Shares
+13.80K
Price / share
$0.84
Trade value
$11.61K
% of position
common stock
Shares
−13.80K
Price / share
$6.00
Trade value
$82.80K
% of position
common stock
Shares
+1.58K
Price / share
$5.11
Trade value
$8.07K
% of position
common stock
Shares
+12K
Price / share
$0.84
Trade value
$10.09K
% of position
common stock
Shares
−12K
Price / share
$6.00
Trade value
$72K
% of position
common stock
Shares
+700.00
Price / share
$0.84
Trade value
$588.77
% of position
common stock
Shares
−700.00
Price / share
$6.00
Trade value
$4.20K
% of position
common stock
Shares
+4.40K
Price / share
$0.84
Trade value
$3.70K
% of position
common stock
Shares
−4.40K
Price / share
$6.01
Trade value
$26.44K
% of position
common stock
Shares
+84.68K
Price / share
$0.84
Trade value
$71.23K
% of position
common stock
Shares
−84.68K
Price / share
$6.01
Trade value
$509.22K
% of position
Net shares
+1.58K
Net value
-$589.39K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| common stock Direct | 12/29/2022 | M · Option Exercise | +13.80K | $0.84 | $11.61K | 49.5% | 27.86K | 41.66K |
| common stock Direct | 12/29/2022 | S · Sale | −13.80K | $6.00 | $82.80K | 33.1% | 41.66K | 27.86K |
| common stock Direct | 12/30/2022 | A · Award | +1.58K | $5.11 | $8.07K | 5.7% | 27.86K | 29.44K |
| common stock Direct | 12/30/2022 | M · Option Exercise | +12K | $0.84 | $10.09K | 40.8% | 29.44K | 41.44K |
| common stock Direct | 12/30/2022 | S · Sale | −12K | $6.00 | $72K | 29.0% | 41.44K | 29.44K |
| common stock Direct | 12/30/2022 | M · Option Exercise | +700.00 | $0.84 | $588.77 | 2.4% | 29.44K | 30.14K |
| common stock Direct | 12/30/2022 | S · Sale | −700.00 | $6.00 | $4.20K | 2.3% | 30.14K | 29.44K |
| common stock Direct | 12/30/2022 | M · Option Exercise | +4.40K | $0.84 | $3.70K | 14.9% | 29.44K | 33.84K |
| common stock Direct | 12/30/2022 | S · Sale | −4.40K | $6.01 | $26.44K | 13.0% | 33.84K | 29.44K |
| common stock Direct | 1/3/2023 | M · Option Exercise | +84.68K | $0.84 | $71.23K | 287.6% | 29.44K | 114.12K |
| common stock Direct | 1/3/2023 | S · Sale | −84.68K | $6.01 | $509.22K | 74.2% | 114.12K | 29.44K |
| Total | +1.58K | -$589.39K | ||||||
Non-Qualified Stock Option (right to buy)
Common Stock
13.80K shares
Shares
−13.80K
Strike price
0.8411
Held after
657.15K
Exercisable
—
Non-Qualified Stock Option (right to buy)
Common Stock
12K shares
Shares
−12K
Strike price
0.8411
Held after
645.15K
Exercisable
—
Non-Qualified Stock Option (right to buy)
Common Stock
700.00 shares
Shares
−700.00
Strike price
0.8411
Held after
644.45K
Exercisable
—
Non-Qualified Stock Option (right to buy)
Common Stock
4.40K shares
Shares
−4.40K
Strike price
0.8411
Held after
640.05K
Exercisable
—
Non-Qualified Stock Option (right to buy)
Common Stock
84.68K shares
Shares
−84.68K
Strike price
0.8411
Held after
555.37K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) Direct | Common Stock13.80K shares | 12/29/2022 | M · Option Exercise | −13.80K | 0.8411 | — | 657.15K |
| Non-Qualified Stock Option (right to buy) Direct | Common Stock12K shares | 12/30/2022 | M · Option Exercise | −12K | 0.8411 | — | 645.15K |
| Non-Qualified Stock Option (right to buy) Direct | Common Stock700.00 shares | 12/30/2022 | M · Option Exercise | −700.00 | 0.8411 | — | 644.45K |
| Non-Qualified Stock Option (right to buy) Direct | Common Stock4.40K shares | 12/30/2022 | M · Option Exercise | −4.40K | 0.8411 | — | 640.05K |
| Non-Qualified Stock Option (right to buy) Direct | Common Stock84.68K shares | 1/3/2023 | M · Option Exercise | −84.68K | 0.8411 | — | 555.37K |